We are live on ! Find out more
YC

Yarbrough Capital Portfolio holdings

AUM $2.85B
1-Year Est. Return 36.22%
This Fund
S&P 500
This Quarter Est. Return
+18.56%
1 Year Est. Return
+36.22%
3 Year Est. Return
+146.68%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.3B
AUM Growth
+$390M
Cap. Flow
+$134M
Cap. Flow %
5.84%
Top 10 Hldgs %
69.61%
Holding
213
New
10
Increased
9
Reduced
8
Closed
18

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$144M
2
NAMS icon
NewAmsterdam Pharma
NAMS
+$486K
3
AXSM icon
Axsome Therapeutics
AXSM
+$424K
4
ONT
Onterris Inc
ONT
+$409K
5
ICLR icon
Icon
ICLR
+$407K

Top Sells

Rank Stock Value
1
CQQQ icon
Invesco China Technology ETF
CQQQ
+$4.67M
2
KWEB icon
KraneShares CSI China Internet ETF
KWEB
+$2.28M
3
NTES icon
NetEase
NTES
+$1.86M
4
SNOW icon
Snowflake
SNOW
+$1.29M
5
DVN icon
Devon Energy
DVN
+$518K

Sector Composition

Rank Sector Weight
1 Technology 38.25%
2 Consumer Discretionary 15.2%
3 Communication Services 14.95%
4 Financials 4.46%
5 Energy 3.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NEOG icon
176
Neogen
NEOG
$2.59B
$329K 0.01%
20,840
– –
IT icon
177
Gartner
IT
$12.4B
$322K 0.01%
676
– –
CTLT
178
DELISTED
CATALENT, INC.
CTLT
$298K 0.01%
5,276
– –
AZEK
179
DELISTED
The AZEK Co
AZEK
$295K 0.01%
5,875
– –
VMI icon
180
Valmont Industries
VMI
$9.43B
$294K 0.01%
1,288
-1,572
-55% -$352K
DHR icon
181
Danaher
DHR
$139B
$293K 0.01%
1,175
– –
INCY icon
182
Incyte
INCY
$24B
$284K 0.01%
4,990
– –
CHWY icon
183
Chewy
CHWY
$9.4B
$276K 0.01%
17,350
– –
STKL
184
DELISTED
SunOpta
STKL
$275K 0.01%
40,044
– –
RSPH icon
185
Invesco S&P 500 Equal Weight Health Care ETF
RSPH
$776M
$269K 0.01%
8,470
– –
THS
186
DELISTED
Treehouse Foods
THS
$269K 0.01%
6,901
– –
TYL icon
187
Tyler Technologies
TYL
$12.5B
$257K 0.01%
605
– –
HAIN icon
188
Hain Celestial
HAIN
$45.5M
$255K 0.01%
+32,451
New +$320K
GOGO icon
189
Gogo Inc
GOGO
$606M
$250K 0.01%
28,526
– –
JNJ icon
190
Johnson & Johnson
JNJ
$613B
$243K 0.01%
1,538
– –
CCRN
191
DELISTED
Cross Country Healthcare
CCRN
$242K 0.01%
12,951
– –
DOCS icon
192
Doximity
DOCS
$3.99B
$231K 0.01%
8,572
– –
AGL icon
193
Agilon Health
AGL
$1.57B
$216K 0.01%
1,413
– –
MRVI icon
194
Maravai LifeSciences
MRVI
$947M
$214K 0.01%
24,731
– –
RVNC
195
DELISTED
Revance Therapeutics, Inc.
RVNC
$60K ﹤0.01%
12,203
– –
BOX icon
196
Box
BOX
$4.39B
– –
-14,190
Closed -$363K
CERT icon
197
Certara
CERT
$1.27B
– –
-12,954
Closed -$228K
CLBT icon
198
Cellebrite
CLBT
$3.76B
– –
-53,492
Closed -$463K
CQQQ icon
199
Invesco China Technology ETF
CQQQ
$3.14B
– –
-129,998
Closed -$4.67M
DVN icon
200
Devon Energy
DVN
$50.8B
– –
-11,445
Closed -$518K
5 6 7
8
9

Similar funds

WG
Winton Group London, United Kingdom $2.85B AUM 30.73% 1-Year Est. Return
MSDF
Michael & Susan Dell Foundation New York $2.85B AUM 26.28% 1-Year Est. Return
AHSSHC
Adventist Health System Sunbelt Healthcare Corp Altamonte Springs, Florida $2.86B AUM 12.86% 1-Year Est. Return
MWM
Meridian Wealth Management Lexington, Kentucky $2.85B AUM 31.23% 1-Year Est. Return
SAI
Systematic Alpha Investments Princeton, New Jersey $2.84B AUM 27.03% 1-Year Est. Return
CAM
Crake Asset Management London, United Kingdom $2.86B AUM 16.35% 1-Year Est. Return
AIP
Atlas Infrastructure Partners London, United Kingdom $2.84B AUM 4.75% 1-Year Est. Return
LIP
Lighthouse Investment Partners Palm Beach Gardens, Florida $2.87B AUM 26.77% 1-Year Est. Return

Yarbrough Capital's Q1 2024 Portfolio in Review

As of Q1 2024, Yarbrough Capital held 213 positions worth $2.3B, up 20% from $1.91B the previous quarter. Its ten largest holdings account for 70% of the portfolio.

Yarbrough Capital deployed $134M of net new capital in Q1 2024, opening 10 new positions and adding to 9 existing holdings. Its largest new stake was NewAmsterdam Pharma: 23,960 shares worth $567K.

By sector, the portfolio is most concentrated in Technology at 38% of assets, down from 40% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was Workday, an estimated $449K trimmed.

  • Yarbrough Capital's largest Q1 2024 buy was NewAmsterdam Pharma: 23,960 shares worth $567K.
  • Yarbrough Capital added most to Amazon in Q1 2024, an estimated $144M increase.
  • Yarbrough Capital's biggest Q1 2024 reduction was Workday, cutting an estimated $449K.
  • Yarbrough Capital fully exited Invesco China Technology ETF in Q1 2024, selling an estimated $4.67M.
  • Yarbrough Capital's ten largest holdings make up 70% of its $2.3B portfolio in Q1 2024.
  • Yarbrough Capital opened 10 new positions and closed 18 in Q1 2024.
  • Yarbrough Capital's portfolio value rose 20% quarter-over-quarter to $2.3B.

Based on Yarbrough Capital's 13F filing for Q1 2024, filed 10 Apr 2024.